ScholarBank@NUS
metadata only
Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
cancer-stem-cellsepigeneticslife-sciences-biomedicinemetastasisoncologyscience-technologytherapeutics
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- METTL3- and IGF2BP1-associated m6A regulation of FADS2 contributes to lipid droplet accumulation and malignant progression in non-small cell lung cancer.#368075
- Exploring Caspase-Independent Apoptosis Mechanism Of New -Carboline Derivatives In Chronic Myelogenous Leukemia#413762
- Liposomes in drugs, nutraceuticals, and cosmetics.#368186
- Gene-guided repurposing identifies dihydroergotamine as a candidate inhibitor of the BCL2-SIVA1 axis in advanced gastric cancer in vitro.#251181
- A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer#349923
Record · ID 653214
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive